01/22/2025
5:57 PM | LaRocca John (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2025
6:00 PM | Rossi Michael J (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2025
6:01 PM | Wilms Joris (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2025
6:03 PM | Gentilcore Douglas J (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2025
6:04 PM | Gad Thomas (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2025
6:05 PM | PFREUNDSCHUH PETER P. (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2025
3:44 PM | LaRocca John (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/13/2025
8:21 AM | Y-mAbs Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2025
8:27 AM | Y-mAbs Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
3:32 PM | Paradigm Biocapital Advisors LP (Filed by)
Y-mAbs Therapeutics (Subject)
| Form SC 13G/A | |
11/08/2024
6:18 AM | Y-mAbs Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
Get the Latest News and Ratings for YMAB and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Y-mAbs Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
11/08/2024
5:55 AM | Y-mAbs Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/04/2024
1:16 PM | VANGUARD GROUP INC (Filed by)
Y-mAbs Therapeutics (Subject)
| Form SC 13G/A | |
11/04/2024
7:51 AM | Y-mAbs Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/17/2024
7:05 PM | Gad Thomas (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
4:24 PM | Y-mAbs Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/13/2024
3:19 PM | Gad Thomas (Reporting)
Y-mAbs Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/12/2024
6:06 AM | Y-mAbs Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/12/2024
5:50 AM | Y-mAbs Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/19/2024
3:15 PM | Y-mAbs Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/12/2024
4:29 PM | PFREUNDSCHUH PETER P. (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/08/2024
6:59 PM | PFREUNDSCHUH PETER P. (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/01/2024
3:20 PM | Y-mAbs Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/13/2024
8:00 PM | TYAGI ASHU (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
8:00 PM | GILL DAVID N (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
8:01 PM | HEALY JAMES (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
8:01 PM | Wedell-Wedellsborg Johan (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
8:02 PM | Hamill Laura (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
8:02 PM | TAGLIAFERRI MARY (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
3:05 PM | Y-mAbs Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/11/2024
6:53 PM | Gad Thomas (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
6:54 PM | Ber Gerard (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
3:44 PM | Gad Thomas (Reporting)
Y-mAbs Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/31/2024
8:36 PM | Kruse Bo (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
5:54 PM | Gad Thomas (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
3:42 PM | Gad Thomas (Reporting)
Y-mAbs Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/29/2024
4:04 PM | Y-mAbs Therapeutics (Filer)
| Form DEFA14A | |
04/29/2024
4:05 PM | Y-mAbs Therapeutics (Filer)
| Form ARS | |
04/29/2024
4:09 PM | Y-mAbs Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/08/2024
4:09 PM | Paradigm Biocapital Advisors LP (Filed by)
Y-mAbs Therapeutics (Subject)
| Form SC 13G | |
03/14/2024
4:01 PM | TAGLIAFERRI MARY (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Market down? Do this now. (Ad) During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now, history is repeating itself.
Here's the truth: Tariffs create uncertainty. Uncertainty drives investors to gold. And gold prices rise as a result. It's a cycle that's already beginning again—and it's your chance to profit.
Why wait? Greed isn't always a bad thing—especially when it comes to protecting and growing your wealth. The smartest investors are already moving their money into gold, and you should too. Download your Free 2025 Gold Guide Now |
03/14/2024
8:17 AM | Y-mAbs Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/08/2024
5:17 AM | TAGLIAFERRI MARY (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/07/2024
4:02 PM | Rajah Vignesh (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
3:49 PM | Smith Susan Laura (Reporting)
Y-mAbs Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/06/2024
3:40 PM | Rajah Vignesh (Reporting)
Y-mAbs Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024
6:05 PM | Gad Thomas (Reporting)
Y-mAbs Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024
5:05 AM | Y-mAbs Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/29/2024
4:04 PM | Y-mAbs Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
